Naciye Türk ÖZTERLEMEZ, Gizem IŞIK, Gözde İnan SEZER, Berrin GÜNAYDIN

Aritmi ablasyon öyküsü olan gebenin spinal anestezi eşliğinde sezaryenle doğumunda anemi yönetimi

Preoperatif dönemde görülen aneminin perioperatif dönemde hastanede kalış süresinin uzaması, yoğun bakım ihtiyacı gibi birçok morbidite ve/veya mortaliteye yol açabilen perioperatif kan transfüzyonu için güçlü bir prediktör olduğu bilinmektedir. Buradaradyofrekans aritmi ablasyon öyküsü olan anemik gebenin spinal anestezi altında elektif sezaryen sırasındaki doğum yönetimini sunmayı hedefledik. Güncel kanıtlara göre, cerrahi öncesinde anemi yönetimine göre, başarısız oral demir tedavisi nedeniyle halen anemik olan gebe olguda spinal anestezi altında sezaryenle doğum sırasında peroperatif tek doz İV demir tedavisi uygulayarak aritmi ablasyon öyküsü olan gebeye yaklaşımımızı sunduk.

Anahtar Kelimeler:

anemi, intravenöz demir tedavisi, sezaryen

Management of anemia in a parturient with an arrthymia ablation history for cesarean delivery under spinal anesthesia

It has been known that preoperative anemia has been a strong predictor for perioperative blood transfusion that may lead to various types of adverse events including longer hospital stay, more ICU admission and morbidity and/or mortality. Hereby, we aimed to present management of an anemic parturient with radiofrequency arrythmiaablation history scheduled for elective cesarean delivery under spinal anesthesia. Based on the recent evidences related to preoperative anemia management, we preferred to correct failed oral iron treatment with a single dose of intravenous iron therapy perioperativelyin our parturient with iron deficiency anemia accordingly.

Keywords:

anemia intravenous iron treatment, cesearean delivery, ; peroperative,

PDF

___

1. Pena-Rosas JP, De-Regil LM, Gomez Malave H, Flores-Urrutia MC, Dowswell T. Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev 2012; 11: 9997.
2. Stevens GA, Finucane MM, De-Regil LM et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health 2013; 1: e16-25.
3. Roy NBA, Pavord S. The management of anaemia and haematinic deficiencies in pregnancy and post-partum. Transfus Med 2018; 28: 107-16.
4. Organization WH. Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. World Health Organization; 2011.
5. Garcia-Casal MN, Pena-Rosas JP, Pasricha SR. Rethinking ferritin cutoffs for iron deficiency and overload. Lancet Haematol 2014; 1: 92-94.
6. Organization WH. WHO recommendations on antenatal care for a positive pregnancy experience: World Health Organization; 2016.
7. Boerma T, Requejo J, Victora CG et al. Countdown to 2030: tracking progress towards universal coverage for reproductive, maternal, newborn, and child health. The Lancet 2018; 391: 1538-48.
8. Spahn DR, Schoenrath F, Spahn GH et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet 2019; 393:2201-12.
9. Targets WGN. 2025: anaemia policy brief. Geneva: World Health Organization. 2014.
10. De Leeuw NK, Lowenstein L, Hsieh YS. Iron deficiency and hydremia in normal pregnancy. Medicine (Baltimore) 1966; 45: 291-315.
11. Bothwell TH. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 2000; 72: 257-64.
12. Guideline W. Daily iron and folic acid supplementation in pregnant women. Geneva: World Health Organization 2012; 27.
13. van Santen S, de Mast Q, Swinkels DW, van der Ven AJ. The iron link between malaria and invasive non-typhoid Salmonella infections. Trends Parasitol 2013; 29 :220-27.
14. Ganz T. Iron homeostasis: fitting the puzzle pieces together. Cell Metab. 2008; 7: 288-90.
15. Moretti D, Goede JS, Zeder C et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood 2015; 126: 1981-89.
16. van der Vorm LN, Hendriks JC, Laarakkers CM et al. Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material. Clin Chem 2016; 62: 993-1001.
17. Lewkowitz AK, Gupta A, Simon L et al. Intravenous compared with oral iron for the treatment of iron-deficiency anemia in pregnancy: a systematic review and meta-analysis. J Perinatol 2019; 39: 519-32.
18. Govindappagari S, Burwick RM. Treatment of Iron Deficiency Anemia in Pregnancy with Intravenous versus Oral Iron: Systematic Review and Meta-Analysis. Am J Perinatol. 2019; 36: 366-76.
19. Holm C, Thomsen LL, Norgaard A, Langhoff-Roos J. Single-dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage: a randomized controlled trial. Vox Sang 2017; 112: 219-28.
20. Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion 2009; 49: 2719-28.
21. Kozek-Langenecker SA, Ahmed AB, Afshari A et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol 2017; 34: 332-95.
22. Froessler B, Cocchiaro C, Saadat-Gilani K, Hodyl N, Dekker G. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial. J Matern Fetal Neonatal Med 2013; 26: 654-59.